tiprankstipranks
Trending News
More News >
UCB SA (DE:UNC)
FRANKFURT:UNC

UCB SA (UNC) Similar Stocks

Compare
24 Followers

Comparison Results

Name
Price
Analyst Price Target
Analyst Consensus
Market Cap
P/E Ratio
Yearly Gain
Top Analysts' Price Target
Smart Score
Follow
UCB SA
€152.45
5 Buy
3 Hold
0 Sell
Moderate Buy
€28.50B
27.20
31.90%
UCB SA
€152.53
5 Buy
3 Hold
0 Sell
Moderate Buy
€28.50B
27.21
34.02%
AstraZeneca
10808.00p
10 Buy
4 Hold
0 Sell
Moderate Buy
£167.59B
30.43
3.89%
GlaxoSmithKline
1417.50p
2 Buy
8 Hold
2 Sell
Hold
£57.57B
22.44
-9.46%
Hikma Pharmaceuticals
1877.00p
4 Buy
2 Hold
0 Sell
Moderate Buy
£4.16B
14.79
3.81%
Indivior
714.00p
6 Buy
0 Hold
0 Sell
Strong Buy
£886.40M
-57.88%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:UNC
UCB SA
152.45
39.35
34.79%
GB:0NZT
UCB SA
152.53
39.31
34.72%
GB:AZN
AstraZeneca
10,808.00
414.25
3.99%
GB:GSK
GlaxoSmithKline
1,417.50
-138.96
-8.93%
GB:HIK
Hikma Pharmaceuticals
1,877.00
92.25
5.17%
GB:INDV
Indivior
714.00
-971.00
-57.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis